Flavonoids as Prospective Aromatase Inhibitors in Breast Cancer Prevention/ Therapy

Area of Science:

• Biochemistry
• Pharmacology
• Nanotechnology

Background:

• Flavonoids show potential as aromatase inhibitors, crucial for cancer therapy.
• Aromatase plays a role in cancer proliferation, particularly in breast and lung cancer.
• Current flavonoid use is limited by poor pharmacokinetics and potential toxicity.

Purpose of the Study:

• To review the aromatase signaling pathway in normal and cancer cells.
• To explore how flavonoids modulate aromatase signaling.
• To discuss nanotechnological approaches for improving flavonoid efficacy and safety.

Main Methods:

• Literature review of aromatase signaling and flavonoid interactions.
• Analysis of flavonoid groups targeting aromatase, including clinical trial data.
• Discussion of nanoparticle-mediated improvements in flavonoid pharmacokinetics and toxicity.

Main Results:

• Flavonoids effectively target aromatase, suppressing cancer cell growth.
• Various flavonoid groups demonstrate aromatase inhibitory activity across different cancers.
• Nanotechnology offers solutions to overcome pharmacokinetic and toxicity challenges of flavonoids.

Conclusions:

• Flavonoids are promising anticancer agents targeting aromatase.
• Nanotechnology enhances the therapeutic application of flavonoids by addressing their limitations.
• Further research into flavonoid-nanoparticle formulations is warranted for cancer treatment.